2-(Hydroxymethyl)-1H-benzimidazole-1-propanoic acid, 97%, 250mg

2-[5-(2-Methylpropyl)-1,2,4-oxadiazol-3-yl]piperidine hydrochloride, 1g

1-Ethyl-3-methyl-1H-pyrazol-4-ylamine dihydrochloride, 95.0%, 5g

NISOLDIPINE, 95%, 1g

Tobramycin, 5g

4'-Bromoacetanilide, 97.00%, 100g

3-(3,4-dichlorophenyl)-2-hydroxyprop-2-enoic acid, 95%, 250mg

1,3-Bis((S)-1-(naphthalen-1-yl)ethyl)-1H-imidazol-3-ium chloride, 97%, 100mg

4-Bromo-1-(2-hydroxyethyl)pyridin-2(1H)-one, 98%, 500mg

Cholesterol (>99%) (stabilized with alpha-Tocopherol)>99.0%(GC)5g

METHYL 3-IODO-1-METHYL-1H-INDAZOLE-6-CARBOXYLATE, 95%, 5g

4,5-Methylenedioxy-1,2-phenylenediamine dihydrochloride, 98%, 250mg

Báscula analítica y de precisión serie Entris® II Modelos con ajuste interno, calibrada de fábrica, 0,01 g, 2200 g, BCE2202i-1CEU